Rifampicin-dependent antibodies during intermittent treatment.
D000888:Antibodies, Anti-Idiotypic; D000917:Antibody Formation / Q000187:drug effects*; D001772:Blood Cell Count; D001792:Blood Platelets / Q000187:drug effects; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D006801:Humans; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D012293:Rifampin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000276:immunology
D000888:Antibodies, Anti-Idiotypic; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D012293:Rifampin